Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Fernando Herrera

Plastic and Reconstructive Surgery Charleston, SC Medical Doctor

NPI 1013164243 CMS profile 626

171 Ashley Ave, Charleston, SC 29425

Open in the dashboard

General payments

$16,423

101 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Fernando Herrera of Charleston, SC is reported in the CMS Open Payments database as having received $16,423 across 101 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $495 7
2024 General $945 11
2023 General $1,133 9
2022 General $5,120 36
2021 General $1,166 17
2020 General $5,404 10
2019 General $2,160 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Fernando Herrera
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Fernando Herrera were reported at $495. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Fernando Herrera Plastic and Reconstructive Surgery median Middle half National median
2019 $2,160 $335 $121–$1,264 $163
2020 $5,404 $162 $57–$417 $114
2021 $1,166 $245 $89–$735 $132
2022 $5,120 $325 $120–$932 $149
2023 $1,133 $343 $129–$999 $160
2024 $945 $390 $141–$1,085 $164
2025 $495 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Kerecis Limited $3,001 5 payments
  2. Musculoskeletal Transplant Foundation Inc. $2,957 3 payments
  3. AxoGen $2,212 7 payments
  4. Allergan Inc. $2,208 33 payments
  5. Peerless Surgical Inc. $1,652 3 payments
  6. Mentor Worldwide LLC $769 9 payments
  7. Sientra, Inc. $738 7 payments
  8. Integra LifeSciences Corporation $636 5 payments
  9. Acera Surgical, Inc. $428 7 payments
  10. AbbVie, Inc. $380 3 payments
  11. Other $1,442 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $11,342 96 payments
  2. Travel and Lodging $3,461 3 payments
  3. Education $1,620 2 payments
Products named General payments · program years 2019–2025
  1. Kerecis Omega3 SurgiClose $2,996 4 payments
  2. Kerecis Omega3 GraftGuide $2,874 3 payments
  3. Kerecis Omega3 Marigen Wound Care $2,726 3 payments
  4. Kerecis Omega3 Marigen Wound Care $2,604 2 payments
  5. Kerecis Omega3 Marigen Wound Care $2,604 2 payments
  6. Avance Nerve Graft $2,071 6 payments
  7. AXOGUARD NERVE PROTECTOR $1,970 4 payments
  8. AxoGuard Nerve Connector $1,970 4 payments
  9. NATRELLE SALINE-FILLED BREAST IMPLANTS $1,542 27 payments
  10. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $738 7 payments
  11. Other $8,520 96 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$63,135

Of which drugs: $9,463

Medicare patients

139

Average age 74

Services billed

693

85 women, 54 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Diabetes 26%
Chronic kidney disease 24%
Depression 23%
Osteoporosis 19%
Ischemic heart disease 16%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 55 96 $74

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

101 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record